Reconsidering transcutaneous bilirubinometry for management of neonatal hyperbilirubinemia: is it time for change?
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Transcutaneous bilirubin assessment (TcB) offers a reliable, non-invasive alternative to total serum bilirubin (TSB) tests for managing neonatal hyperbilirubinemia. This approach can reduce painful procedures for newborns without increasing the risk of neurotoxicity.
Area Of Science
- Neonatal Medicine
- Pediatric Care
- Clinical Chemistry
Background
- Current hyperbilirubinemia management relies on total serum bilirubin (TSB), despite concerns about painful neonatal procedures.
- TSB's role as the gold standard for neurotoxicity risk is not directly evidenced.
- TSB measurements have inherent laboratory variability.
Purpose Of The Study
- To evaluate transcutaneous bilirubin assessment (TcB) as a reliable alternative to TSB.
- To explore reducing painful procedures in neonates through TcB utilization.
- To challenge the assumption of TSB's definitive role in assessing neurotoxicity risk.
Main Methods
- Extensive review of studies correlating transcutaneous bilirubin assessment (TcB) with total serum bilirubin (TSB).
- Analysis of TSB's limitations, including laboratory variability and lack of direct neurotoxicity correlation.
- Evaluation of TcB's advantages: non-invasiveness, reduced turnaround time, and cost-effectiveness.
Main Results
- TcB's reliability is currently inferred solely from its correlation with TSB.
- TSB levels lack direct evidence linking them to specific risks of bilirubin-induced neurotoxicity.
- TcB avoids invasive procedures, offers faster results, and reduces healthcare costs.
Conclusions
- TcB can serve as a reliable method for managing neonatal hyperbilirubinemia.
- Standardizing TcB and updating guidelines can significantly decrease painful interventions for neonates.
- Implementing TcB does not appear to elevate the risk of bilirubin neurotoxicity.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...